Skip to main content
S. 2044 118th Congress Senate

End Price Gouging for Medications Act

Official title: A bill to require the Secretary of Health and Human Services to establish reference prices for prescription drugs for purposes of Federal health programs, and for other purposes.

Introduced: June 20, 2023 Introduced by: Jeff Merkley Democratic · Oregon See on congress.gov
Health AsiaAustraliaCanadaCivil actions and liability
More subjectsShow fewer subjects
EuropeFranceGermanyHealth care costs and insuranceHealth care coverage and accessInflation and pricesItalyJapanMedicaidMedical researchMedicareMilitary medicineNetherlandsNorth AmericaOceaniaPrescription drugsRetail and wholesale tradesSpainSwedenSwitzerlandUnited KingdomVeterans' medical care
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 20, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 20, 2023
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action June 20, 2023

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Plain-English summary Congressional Research Service

End Price Gouging for Medications Act

This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including the lowest retail price for a drug among specified reference countries.

Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.

 Related & companion bills 1
  • HR 4215 Identical bill End Price Gouging for Medications Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1
D
Welch, Peter
Vermont · Jun 20, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2044: End Price Gouging for Medications Act. 118th Congress. Open America. https://openamerica.io/bill/118-S-2044/
MLA
"S. 2044: End Price Gouging for Medications Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-2044/.
Bluebook (legal)
S. 2044, 118th Cong. (2026), https://openamerica.io/bill/118-S-2044/.
Markdown link
[S. 2044: End Price Gouging for Medications Act](https://openamerica.io/bill/118-S-2044/)
Report a problem